RISK-FACTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION AMONG OUT-OF-TREATMENT DRUG INJECTORS IN HIGH AND LOW SEROPREVALENCE CITIES

被引:123
作者
FRIEDMAN, SR [1 ]
JOSE, B [1 ]
DEREN, S [1 ]
JARLAIS, DCD [1 ]
NEAIGUS, A [1 ]
机构
[1] BETH ISRAEL MED CTR, INST CHEM DEPENDENCY, NEW YORK, NY 10003 USA
关键词
ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV; INCIDENCE; LESBIANISM; RISK FACTORS; SEX BEHAVIOR; SUBSTANCE ABUSE; INTRAVENOUS;
D O I
10.1093/oxfordjournals.aje.a117726
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
From 1988 to 1991, 6,882 drug injectors in 15 US cities were interviewed and had serum samples collected. The interviews and samples were analyzed for determination of significant predictors of human immunodeficiency virus (HIV) seroconversion in the 10 low seroprevalence cities and the five high seroprevalence cities. The unit of analysis was the period of observation between consecutive paired interviews/blood samples. In Cox proportional hazards regression, significant predictors of seroconversion in the low seroprevalence cities were: not being in drug treatment, injecting in outdoor settings or abandoned buildings, using crack cocaine weekly or more frequently, engaging in woman-to-woman sex, being of non-Latino race/ethnicity, and city seroprevalence. Predictors in high seroprevalence cities were: injecting with potentially infected syringes, not being in drug treatment, and having a sex partner who injected drugs. These findings suggest that HIV may be concentrated in sociobehavioral pockets of infection in low seroprevalence cities. For reducing HIV transmission, these results suggest: 1) in low seroprevalence cities, localized monitoring to detect specific emerging sociobehavioral pockets of infection, and quick implementation of appropriate targeted interventions if necessary; 2) in high seroprevalence cities, relatively mor emphasis on locality-wide outreach and syringe-exchange projects to reduce risky behavior; and 3) in both types of cities, considerable expansion of drug treatment programs.
引用
收藏
页码:864 / 874
页数:11
相关论文
共 42 条
  • [1] NEW EVIDENCE ON INTRAVENOUS COCAINE USE AND THE RISK OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ANTHONY, JC
    VLAHOV, D
    NELSON, KE
    COHN, S
    ASTEMBORSKI, J
    SOLOMON, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) : 1175 - 1189
  • [2] BATTJES RJ, 1989, J ACQ IMMUN DEF SYND, V2, P533
  • [3] BROWN BS, 1993, HDB RISK AIDS
  • [4] COCAINE USE AND HIV INFECTION IN INTRAVENOUS DRUG-USERS IN SAN-FRANCISCO
    CHAISSON, RE
    BACCHETTI, P
    OSMOND, D
    BRODIE, B
    SANDE, MA
    MOSS, AR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (04): : 561 - 565
  • [5] AIDS RISK REDUCTION AND REDUCED HIV SEROCONVERSION AMONG INJECTION-DRUG USERS IN BANGKOK
    DESJARLAIS, DC
    CHOOPANYA, K
    VANICHSENI, S
    PLANGSRINGARM, K
    SONCHAI, W
    CARBALLO, M
    FRIEDMANN, P
    FRIEDMAN, SR
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) : 452 - 455
  • [6] DESJARLAIS DC, 1992, J SUBST ABUSE TREAT, V9, P319
  • [7] HIV-1 INFECTION AMONG INTRAVENOUS DRUG-USERS IN MANHATTAN, NEW-YORK-CITY, FROM 1977 THROUGH 1987
    DESJARLAIS, DC
    FRIEDMAN, SR
    NOVICK, DM
    SOTHERAN, JL
    THOMAS, P
    YANCOVITZ, SR
    MILDVAN, D
    WEBER, J
    KREEK, MJ
    MASLANSKY, R
    BARTELME, S
    SPIRA, T
    MARMOR, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (07): : 1008 - 1012
  • [8] DESJARLAIS DC, 1992, AIDS OTHER MANIFESTA, P645
  • [9] DETELS R, 1989, J ACQ IMMUN DEF SYND, V2, P77
  • [10] FRIEDMAN SR, 1994, HIV EPIDEMIOLOGY, P137